Key result
Between 1992 and 1997, the proportion of primary cancer resections performed by high-volume consultant firms increased for breast, colorectal, and ovarian cancers.
Why the study?
Is there evidence of increasing numbers of patients with breast, colorectal or ovarian cancer being treated by high-volume sub-specialist surgeons?
Observational (n=28,356)
Yes
Is there evidence of increasing numbers of patients with breast, colorectal or ovarian cancer being treated by high-volume sub-specialist surgeons?
There is a trend towards sub-specialization in breast cancer surgery, but weaker trends in colorectal and ovarian cancer surgery highlight the need for continued monitoring of surgical volumes.
Answers are grounded in this paper and cite their sources.
Supports sub-specialization trends in select cancers; leaves open outcome benefits and need for prospective volume monitoring.
The 'Calman-Hine Report' (1995) recommended that cancer surgery should be limited to 'high-volume' consultants. Through an analysis of 5 years of Hospital Episode Statistics for the West Midlands region (1992-1997), we have investigated whether there is evidence of increasing numbers of patients with breast, colorectal or ovarian cancer being treated by high throughput, i.e. sub-specialist surgeons, who carry out more than a threshold level of primary cancer resections annually. The proportion of cases treated by the high-volume breast, colorectal and ovarian cancer surgeons increased annually during the 5 years. The absolute number of consultant firms who undertook breast cancer resections reduced during the 5 years; but the number doing colorectal and ovarian surgery increased. Throughout the 5 years, half of the ovarian cancer resections were carried out by consultant firms who did very few procedures - less than 5 of these procedures annually. The relatively high case-load, the elective nature of breast cancer surgery and an early policy change have undoubtedly facilitated the move towards sub-specialization. The weaker trends for colorectal and ovarian cancer surgery suggest continued monitoring is required to ensure that there is a reduction in the proportion of people treated by surgeons who undertake few cancer resections annually.
No takes yet. Share an insight, caveat, or question.
Jolly et al. (2001) conducted an observational in Breast, colorectal, and ovarian cancer (n=28,356). Treatment by high-volume consultant firms vs. Treatment by lower-volume consultant firms was evaluated on Trend in the proportion of cases managed by a high-volume consultant firm over the study period (p=<0.001). Between 1992 and 1997, the proportion of primary cancer resections performed by high-volume consultant firms increased for breast, colorectal, and ovarian cancers.
Synapse has enriched 10 related papers. Consider them for comparative context: